STANDARD BIOTOOLS INC. (LAB) Shareholders’ equity 2016–2025
STANDARD BIOTOOLS INC. (LAB) shareholders’ equity at each fiscal year-end, per SEC filings.
$424.3MFY2025 · since FY2016: $53.2M → $424.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $424.3M | -10.1% |
| FY2024 | $471.7M | +418.6% |
| FY2023 | -$148.1M | -81.7% |
| FY2022 | -$81.5M | -186.1% |
| FY2021 | $94.6M | -32.0% |
| FY2020 | $139.1M | -9.5% |
| FY2019 | $153.6M | +113.0% |
| FY2018 | $72.1M | +133.1% |
| FY2017 | $30.9M | -41.9% |
| FY2016 | $53.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice